Clinical effect of lowering heart rate in sepsis syndromes; comparing ivabradine 10 mg and 15 mg versus placebo.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Ivabradine (Primary)
- Indications Multiple organ failure; Sepsis; Septic shock
- Focus Therapeutic Use
- 16 Sep 2016 New trial record